Grass City 20% OFF

CORAL GABLES, FL / ACCESSWIRE / December 26, 2018 / A poll by Gallup has shown that as many as 64% of Americans support the legalization of cannabis and agree that it is a safe plant with a large amount of health benefits. In tandem with these statistics, marijuana stocks have seen quite a bit of excitement this year. With 2019 only a week away, Premier Health Group (OTC:PHGRF) (CNSX:PHGI.CN) , Aurora Cannabis (NYSE:ACB), Tilray Inc (NASDAQ:TLRY), and Aphria Inc (NYSE:APHA) are 4 marijuana stocks to pay attention to heading into the New Year.

Earlier this month, Premier Health Group (OTC:PHGRF) (CNSX:PHGI.CN) hit highs of 0.80 to mark a move of more than 30% over the course of the last 30 days. The company has been largely focusing its efforts on growth in the healthcare and cannabis industries. Last week, The Company announced that it has signed a binding LOI to acquire all of the outstanding securities of Cloud Practice Inc.

Dr. Essam Hamza, CEO of Premier Health, said,”We are ecstatic at the opportunity to build on our patient-centric technology platform through the integration of Cloud Practice’s suite of software solutions. They have a strong team of developers who are just as enthusiastic as we are about the future of healthcare. We believe that this partnership will help facilitate our vision of integrating telemedicine, online booking, and other premium services with our electronic medical record (EMR) system.”

According to the company’s announcement , Cloud Practice already has a tremendous standalone and growing business serving thousands of clinicians and millions of patients. The collective ecosystem of over 3,000,000 patients creates an opportunity to become a key player in the telehealth space in Canada.

For More Information On Premier Health Group, Click Here

Aurora Cannabis (ACB) made headlines earlier this month when the Company announced that it had entered into an agreement to invest $10 million by way of a brokered private placement in High Tide Inc., a privately held, Alberta-based, retaiol-focused cannabis and lifestyle accessories company.

“In addition to four operational cannabis retail stores, High Tide has developed a broad network of smoking accessories and cannabis lifestyle stores that feature unique products, supported by strong branding that has resonated well with Canadian consumers,” said Terry Booth, CEO of Aurora. “Through our investment, we gain exposure to two unique retail store concepts currently launching across Canada, as well as established cannabis culture brands and thousands of proprietary accessories. We look forward to working with the team at High Tide and supporting them as they execute on their aggressive growth strategy.”

For More Information On Aurora Cannabis, Click Here

Tilray Inc (TLRY) announced, several weeks ago that the Company would be partnering up with AB InBev, one of the world’s leading beverage producers, to research non-alcohol beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD). The partnership is limited to Canada and decisions regarding the commercialization of the beverages will be made int he future.

”We are delighted to be joining forces with a world-leading beverage company, AB InBev, to research how to create enjoyable cannabis beverage products. Tilray and AB InBev share a commitment to responsible product development and marketing, and we look forward to beginning our work on this important partnership as Tilray continues to pioneer the development of a professional, transparent, and well-regulated cannabis industry,” said Brendan Kennedy, CEO of Tilray.

For More Information On Tilray Inc, Click Here

Aphria Inc, (APHA), one of Canada’s leading producers of medical cannabis, announced at the tail-end of last week that the Company had completed its second shipment of approximately 20 kg of medical cannabis to its Australian-based partner Althea Company Pty Ltd.

According to the official press release, under a previously announced supply agreement with Althea, Aphria is providing packaged co-branded cannabis oil and dried flower products for the Australian medical cannabis market. Prior to shipment, the Australian Governments’ Office of Drug Control issued an import certificate and Health Canada issued an export certificate.

”We are thrilled to complete this second shipment and by the fast-growing demand for Aphria co-branded medical cannabis in Australia,” said Jakob Ripshtein, President of Aphria.”Through investments and valuable partners like Althea, Aphria continues to execute on its strategic plan for international expansion, growing our presence in high-value global markets.”

For More Information On Aphria Inc, Click Here

About is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns , may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns , may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of, MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 -4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid”500,000” shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the”500,000” shares of Premier Health Group Inc., that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. As of December 26, 2018 a member of MAPH holds 116 Aurora Call Options and 30,000 shares of Aurora purchased in the open market and may be sold at any time. Click here for our full disclaimer .